FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to a high-sensitivity method for measuring the amount of individual's blood plasma glycyrrhizin, glycyrrhetinic acid and their pharmaceutically acceptable salts. The high-sensitivity method for measuring the amount of glycyrrhizin, glycyrrhetinic acid and their pharmaceutically acceptable salts is characterised by the fact that a mixture of individual's blood plasma with methanol or ammonia water in the specific concentration is introduced into a solid phase having the reverse-phase distribution function and the anion exchange function; the solid phase is then washed with a cleaning fluid that is a single-component fluid or a mixed fluid of at least two components specified in a group containing water, alkali, alcohol and acetonitrile. That is followed by elution from the solid phase in acid alcohol specified in formic acid - methanol or formic acid - ethanol; that is followed by the stage of measuring glycyrrhizin, glycyrrhetinic acid and their pharmaceutically acceptable salts by liquid chromatography - mass spectrometry or liquid chromatography - mass spectrometry/mass spectrometry.
EFFECT: high-sensitivity method enables detecting and measuring the amounts of individual's blood plasma glycyrrhizin, glycyrrhetinic acid and their pharmaceutically acceptable salts.
4 dwg, 17 tbl, 7 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR QUANTITATIVE DETERMINATION OF DEXAMETHASONE IN BIOLOGICAL MEDIA USING HPLC WITH ULTRAVIOLET DETECTION | 2022 |
|
RU2792274C1 |
METHOD OF QUANTITATIVE DETERMINATION OF 8-(TRIFLUOROMETHYL)BENZO[f][1,2,3,4,5]PENTATHIEPIN-6-AMINE HYDROCHLORIDE IN BIOLOGICAL MEDIA | 2018 |
|
RU2676487C1 |
COMPOSITIONS COMPRISING ENZYME-CLEAVABLE KETONE-MODIFIED OPIOID PRODRUGS AND OPTIONAL INHIBITORS THEREOF | 2010 |
|
RU2600736C2 |
METHOD FOR DETERMINING DABIGATRAN IN HUMAN BLOOD SERUM | 2018 |
|
RU2683032C1 |
COMPOSITIONS CONTAINING ENZYMATIC DECOMPOSABLE OXYCODONE PRODRUG | 2012 |
|
RU2609412C2 |
METHOD FOR QUANTITATIVE DETERMINATION OF DISULPHIRAM IN BIOLOGICAL MEDIA | 2019 |
|
RU2701524C1 |
METHOD FOR DETERMINING LOSARTAN, ITS MAIN METABOLITE LOSARTAN CARBOXYLIC ACID AND GLIBENCLAMIDE IN HUMAN BLOOD SERUM AND URINE | 2020 |
|
RU2749567C1 |
METHOD FOR DETERMINING AMIODARONE AND ITS MAIN METABOLITE DESETHYLAMIODARONE IN HUMAN BLOOD SERUM | 2020 |
|
RU2749566C1 |
METHOD OF QUANTITATIVE DETERMINATION OF ANTIHYPERTENSIVE AGENTS IN BLOOD PLASMA | 2022 |
|
RU2803887C1 |
SUBSTITUTED ARYLSULFONAMIDES AS ANTIVIRAL AGENTS | 2007 |
|
RU2423352C2 |
Authors
Dates
2015-07-27—Published
2011-11-15—Filed